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Objective: To explore the effect of salinomycin on the metastasis and invasion of
bladder cancer cell line T24 by regulating the related protein expression in the process of
epithelial–mesenchymal transition (EMT), and to provide experimental basis for the
treatment of urological tumors.
Methods: The bladder cancer cell line T24 was cultured in vitro. The rat bladder tumor
model was established in vivo. The rats were randomized into two groups, among which
the rats in the experiment group were given intraperitoneal injection of salinomycin,
while the rats in the control group were given intraperitoneal injection of normal saline.
The change of tumor cells in the two groups was observed. Transwell was used to detect
the cell migration and invasion abilities, Real-time PCR was used to detect the expression
of mRNA, while Western-blot was utilized for the determination of the expressions of E-
cadherin and vimentin proteins.
Results: The metastasis and invasion abilities of serum bladder cancer cell line T24 after
salinomycin treatment in the experiment group were signiﬁcantly reduced when
compared with those in the control group, and the tumor metastasis lesions were
decreased from an average of 1.59 to 0.6 (P < 0.05). T24 cell proliferation in the
experiment group was gradually decreasing. T24 cell proliferation at 48 h was signiﬁ-
cantly lower than that at 12 h and 24 h (P < 0.05). T24 cell proliferation at 24 h was
signiﬁcantly lower than that at 12 h (P < 0.05). T24 cell proliferation at each timing point
in the experiment group was signiﬁcantly lower than that in the control group (P < 0.05).
The serum mRNA level and E-cadherin expression in the tumor tissues in the experiment
group were signiﬁcantly higher than those in the control group, while vimentin expression
level was signiﬁcantly lower than that in the control group (P < 0.05).
Conclusions: Salinomycin can suppress the metastasis and invasion of bladder cancer
cells, of which the mechanism is probably associated with the inhibition of EMT of tumor
cells.1. Introduction
The invasion and metastasis of tumor cells are the basic
characteristics of malignant tumors. Along with the progression
of the disease, the cell adhesive capability is weakening, while
the invasion ability of tumor cells in gradually increasing. The
metastasis and invasion of tumor cells is a multi-factor, multi-stage, and multi-step process [1,2]. Experiments demonstrate that
[3] the invasion and metastasis of tumor cells are closely
associated with the process of epithelial–mesenchymal
transition (EMT). EMT plays a vital role in embryonic
development, tissue reconstruction, chronic inﬂammation, and
various ﬁbrosis diseases with a main characteristic of
increasing vimentin expression and decreasing E-cadherin
expression. E-cadherin is a member of calcium adhesin
superfamily, and its function activity and expression intensity
have a direct action on the separation and reattachment of
cells. Vimentin is a kind of protein of intermediate ﬁlaments,
can maintain the cell shape and the integrity of cytoplasm, andticle under the CC BY-NC-ND
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biological properties of cells [4].
Bladder cancer is a kind of urological tumor with a relatively
high morbidity and recurrence metastasis rate. The early treat-
ment for bladder cancer is mainly adopting local lesion resec-
tion, but postoperative metastasis occurs in 60% patients, 20%
patients are progressed to the middle and advanced stage;
moreover, the ﬁve-year survival rate is less than 50% [5].
Therefore, developing a new kind of anti-tumor drug is
becoming a medical research emphasis currently. With the
development of biopharmaceutical technology, a large amount
of new antibiotics with unique molecular structures are
constantly developing. In recent years, there are constant re-
searches on salinomycin in inhibiting the metastasis and inva-
sion of tumor cells, but there are fewer researches on
salinomycin in inhibiting bladder tumor cells. In order to deeply
comprehend that the salinomycin can inhibit the tumor cells by
regulating the EMT process, a bladder cancer rat model is
established in the experiment, and the rats were injected with
salinomycin to observe the change of E-cadherin and vimentin
expressions and the effect on the metastasis and invasion of
bladder transitional cancer cell line T24.
2. Materials and methods
2.1. Materials
The human bladder transitional cancer cell line T24 was
provided by the Experimental Center of Zhongshan University.
Salinomycin was purchased from Sigma Aldrich. Transwell and
matrigel were purchased from BD Biosciences. DMEM, DMSO,
pancreatin, and fetal bovine serum were purchased from Gibco.
Anti-mouse vimentin and E-cadherin were provided by Santa
Cruz Biotechnology. TRIzol was purchased from in vitro-gen.
PCR kits were purchased from TaKaRa. A total of 10 male rats
weighing (6–10 g) were raised in SPF laminar ﬂow cabinet of
the Afﬁliated Hospital of Zhongshan University. All the ma-
nipulations abided by the related provisions of Experimental
Animal Committee of Guangdong Province. The salinomycin
(50 mM) used in the experiment was a mixed preparation of
salinomycin and DMSO.
2.2. Methods
2.2.1. Cell culture and passage
T24 was taken from the liquid nitrogen container and quickly
placed in the water bath at 37 C for unfreezing. The nutrient
solution (10 mL) was absorbed, added to the centrifuge tube, and
centrifuged at 1000 r/min for 5 min. After T 24 was unfreezing,
the thawing ﬂuid was sucked, inoculated in DMEM nutrient
solution containing 10% fetal bovine serum, placed in an incu-
bator at 37 C with a saturation humidity of 5% CO2 for culti-
vation. The nutrient solution was changed every other day. The
cell growth was observed under a microscope. The cells were
sub-cultured using 0.25% pancreatin and 0.02% EDTA. Cells in
a logarithmic phase were used for the experiment.
2.2.2. Animal model preparation and grouping
A total of 10 male rats were used in the experiment. After a
routine anesthesia, the abdomen was opened. After aresuspension of high glucose medium not containing serum
DMEM, and matrigel, the bladder transitional cancer cell line
T24 was inoculated in the parenchyma of bladder in rats, and
then the abdomen was sutured. After operation, the rats were
randomized into the experiment group and the control group
with ﬁve in each group. After operation, the rats in the experi-
ment group were immediately given intraperitoneal injection of
salinomycin with a dosage of 8 mg/kg, while the rats in the
control group were given intraperitoneal injection of normal
saline. A close observation was paid during the drug adminis-
tration period. After 15 d, the rats were sacriﬁced by cervical
dislocation, and the complete tumor tissues were stripped to
observe the tumor growth and metastasis.
2.2.3. Detection of cell migration and invasion abilities
by Transwell
Rat cells in each group were extracted by Trizol and inoc-
ulated in a six pore plate. The cell density was adjusted to
5 × 106/mL. A volume of 200 mL cells were taken and placed
in Transwell chamber containing 500 mL 20% serum medium
for cultivation. After 36 h cultivation, the medium was sucked,
and the cells in the upper chamber were removed, ﬁxed with
4% paraformaldehyde, stained with crystal violet for 15–
30 min, and washed three times with PBS. The cells were
observed under a microscope and recorded. During the inva-
sion assay, 30 mL matrigel was added to the upper chamber,
and the rest procedures were the same as the migration
experiment.
2.2.4. Detection of mRNA expression by real-time PCR
RNA was extracted in strict accordance with the Omniscript
RT kit instruction, and reversely transcribed to obtain cDNA.
PCR was used to analyze the expressions of E-cadherin and
vimentin. b-actin was used as an internal control. The primer
sequences were as the following: vimentin upper stream primer:
ATTTTCCCCTCGACAGCCGAT, vimentin down stream
primer: TCCCAGGCGTAGACCAATA, E-cadherin upper
stream primer: AGTCCACTGAGTAGCGCAGAC, E-cadherin
down stream primer: CATTTCACGCATCTGGGGTTC. PCR
reaction conditions were as the following: 95 C 30 s, 95 C 5 s,
60 C 45 s, a total of 42 circulations. 2−DDCt was used to analyze
the relative intensity of mRNA. The experiment was repeated
three times and the average values were taken.
2.2.5. Determination of E-cadherin and vimentin
expressions by western blot
RIPA lysate was used to provide proteins in the adherent
cells. RIPA lysate and protease inhibitor were prepared ac-
cording to a ratio of 100:1. After a lysis, the cells were placed on
the ice for 1 h, vibratingly dissociated every 20 min, and
centrifuged at 4 C 12000 r/10 min. The supernatant was
extracted, and western blot was used to determine the E-cadherin
and vimentin expressions.
2.3. Statistical analysis
SPSS 17.0 software was used for statistical analysis. The
measurement data were expressed as mean ± SD and t test was
used. P < 0.05 was regarded as statistically signiﬁcant
difference.
Table 1
Comparison of the cell proliferation between the two groups (OD value).
Groups n 12 h 24 h 48 h
Experiment group 5 0.22 ± 0.01* 0.15 ± 0.03* 0.09 ± 0.01*
Control group 5 1.14 ± 0.05 1.07 ± 0.02 1.09 ± 0.03
*P < 0.05, when compared with the control group.
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3.1. Effect of salinomycin on T24 metastasis and
invasion
The metastasis and invasion abilities of serum bladder cancer
cell line T24 after salinomycin treatment in the experiment
group were signiﬁcantly reduced when compared with those in
the control group, and the tumor metastasis lesions were
decreased from an average of 1.59 to 0.6 (P < 0.05). T24 cell
proliferation in the experiment group was gradually decreasing.
T24 cell proliferation at 48 h was signiﬁcantly lower than that at
12 h and 24 h (P < 0.05). T24 cell proliferation at 24 h was
signiﬁcantly lower than that at 12 h (P < 0.05). No obvious
change of T24 cell proliferation at each timing point in the
control group (P > 0.05). T24 cell proliferation at each timing
point in the experiment group was signiﬁcantly lower than that
in the control group (P < 0.05) (Table 1).Figure 1. Histological observation (×200).3.2. Histological observation
The microscopic results showed that in the study group, at
the time of 12 h, the number of T24 cell was decreased, the
adherent ability was reduced, partial cells turned to an oval or
circle shape, the transparency of the cytoplasm was reduced,
and the number of cell nucleus was decreased; at the time of
24 h, a small part of T24 cells lost a normal shape, turning a
circle shape, the number was signiﬁcantly reduced, partial cell
debris could be seen or there was an occurrence of irregular
sprouting; at the time of 48 h, a large part of T24 cells lost a
normal shape, a large amount of cells were ﬂoating, more cell
debris, cell nucleus pycnosis, and cell membrane lysis could
be seen. In the control group, at the time of 12 h, T24 cells
entered a logarithmic phase, the number of cells was increased
with a tight arrangement, some mitotic ﬁgure could be seen,
the cells could grew well in the following timing point
(Figure 1).
3.3. Effect of salinomycin on EMT process
The serum mRNA level and E-cadherin expression in the
tumor tissues in the experiment group were signiﬁcantly higher
than those in the control group, while vimentin expression level
was signiﬁcantly lower than that in the control group (P < 0.05)
(Figure 2).
Figure 2. Determination of E-cadherin and vimentin expressions by Western blotting.
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Tumor is a neoplasm formed in an abnormal hyperplasia of
monoclonicity arising from a lost regulation to the cell growth in
a gene level under the effect of various factors [6]. The invasion
and metastasis of tumor cells are a complicated process, i.e.,
cancer cells are separating from the primary tumor site, and
establish a metastasis lesion in a remote place [7]. The typical
metastasis process of cancer cells is that a remote metastasis is
achieved by the lost cell growth inhibition ability and the
degradation of extracelluar matrix components through altering
the cell adhesive force and the activity of cell proliferation
related enzymes [8].
Bladder cancer is characterized by a high recurrence rate,
strong cell invasion ability, and a high mortality. Surgical
operation is a main method to treat non invasive bladder cancer.
A perfusion of chemotherapy or immunotherapy drugs to the
bladder cavity is given according to the tumor staging and
pathological grading after operation [9]. Chemotherapy can
effectively reduce the recurrence rate of bladder cancer, but
the chemotherapeutics are toxic and may pose some damage
to the body immune functions. Patients will abandon the
chemotherapy mostly due to intolerance, resulting in an
unsatisfactory long-term efﬁcacy [10]. Therefore, exploring a
new method to treat bladder cancer is an urgent tissue
required to be resolved in the clinic. With the development of
molecular biology and genomics, new anticancer drugs are
constantly emerging.
Salinomycin is a kind of monocarboxylic acid polyether type
antibiotics, produced by the fermentation of Streptomyces albus,
possesses a speciﬁc cyclic structure, and can form a complex
compound with the pathogenic microorganisms and the extra-
cellular cations of coccidian, especially K+, Na+, Rb+, to alter the
intracellular and extracellular ion concentrations. The complex
compound is transported to the cells by the bacteria or transport
protein to destroy the intracellular and extracellular ion balance,
leading to an inactivation of cells [16–20]. Foreign researches
demonstrated that salinomycin can inhibit the metastasis and
invasion of breast cancer cells in rats, and induce the cell
apoptosis [11]. Guo et al. reported that [12] salinomycin in vivo
and in vitro can inhibit the expression of Wnt/b-catenin in the
liver cancer cells. Mao et al. found that [13] salinomycin can
inhibit the invasion and metastasis of gastric cancer cells.
Antoszczak found that [14] salinomycin can inhibit the growth
of osteogenic sarcoma cells. Calzolari et al. veriﬁed that [15]
salinomycin can up regulate the E-cadherin expression in colon
cancer cells. In the study, the metastasis and invasion abilities
of serum bladder cancer cell line T24 in the experiment group
was signiﬁcantly reduced (P < 0.05), T24 cell proliferation was
gradually decreasing, and T24 cell proliferation in each timing
point was signiﬁcantly lower than that in the control group
(P < 0.05). The histological observation results showed that in
the experiment group, salinomycin can signiﬁcantly promotethe apoptosis of bladder cancer cell line T24 and inhibit the
proliferation, suggesting that salinomycin has a signiﬁcant
inhibition effect on T24 cell proliferation. Moreover, the serum
mRNA level and E-cadherin expression in the tumor tissues in
the experiment group were signiﬁcantly higher than those in the
control group, while vimentin expression level was signiﬁcantly
lower than that in the control group (P < 0.05), showing that
salinomycin can suppress EMT process through up regulating
E-cadherin expression and down regulating vimentin expression
in order to inhibit the metastasis and invasion of tumor cells.
The results in the study showed that the alterations of E-
cadherin and vimentin expressions in the tumor cells are prob-
ably the main mechanism for changing the metastasis and in-
vasion abilities of tumor cells. Salinomycin can suppress the
expressions of E-cadherin and vimentin in the bladder cancer
cells and has a signiﬁcant inhibition effect on the metastasis and
invasion of bladder cancer cells.
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